© 2022 HealthCore Inc.
menu
search
menu
search
Sponsor
April 2022

HealthCore is a proud sponsor of ISPOR 2022: the leading global conference for health economics and outcomes research! Visit us at Booth #500 (or virtually), connect with our experts, and see our latest research.

Both in-person and virtual conference registration includes extended access to all session playback recordings as well as virtual posters and networking through June 17, 2022. For more information, please visit https://www.ispor.org/conferences-education/conferences/upcoming-conferences/ispor-2022.

Workshop

Concurrent Breakout Session 5 | Tuesday, May 17 | 1:30–2:30 pm ET

219 | Best Practices for Causal Study Designs Using Real-World Data

Discussion Leader: Michael Grabner, PhD1
Discussants: Nilesh Gangan, PhD1, Susan dosReis, PhD2
1HealthCore, Inc., Wilmington, DE, USA, 2University of Maryland School of Pharmacy, Baltimore, MD, USA

HealthCore ISPOR 2022 Causality Workshop [PDF]

 

HealthCore Poster Presentations

Sunday, May 15 – Wednesday, May 18

Click the title of each poster below to view the abstract.
*HealthCore authors are indicated in bold.
Session Topic Title Authors Affiliations

Monday, May 16

Poster Session 1

12:15 – 1:15 PM EDT

CLINICAL OUTCOMES / DIABETES / ENDOCRINE / METABOLIC DISORDERS

CO30 | Clinical Experiences of Type 2 Diabetes (T2DM) Patients Initiating Oral Semaglutide

Dunn TJ1, Swift C1, Guesnier A1, Noone J1, Willey V2

1Novo Nordisk Inc., Plainsboro, NJ, USA, 2HealthCore, Inc., Wilmington, DE, USA

Monday, May 16

Poster Session 1

12:15 – 1:15 PM EDT

METHODOLOGICAL & STATISTICAL RESEARCH / NO ADDITIONAL DISEASE & CONDITIONS / SPECIALIZED TREATMENT AREAS

MSR11 | A Step-By-Step Guide for Causal Study Design When Estimating Treatment Effects Using Real-World Data

HealthCore ISPOR 2022 Causality Poster [PDF]

Causal Study Design Guide and Glossary [PDF]

Hoffman S1, Gangan N1, Chen X2, Smith JL1, Tave A1, Yang Y1, dosReis S3, Grabner M1

1HealthCore, Inc., Wilmington, DE, USA, 2Anthem, Inc., Indianapolis, IN, USA, 3University of Maryland School of Pharmacy, Baltimore, MD, USA

Tuesday, May 17

Poster Session 3

12:15 – 1:15 PM EDT

CLINICAL OUTCOMES / DIABETES / ENDOCRINE / METABOLIC DISORDERS
Top 5% Finalist for the ISPOR 2022 Research Presentation Awards

CO94 | Changes in Demographic and Clinical Characteristics of Patients with Type 2 Diabetes (T2DM) Initiating Subcutaneous Semaglutide

Dunn TJ1, Swift C1, Guesnier A1, Noone J1, Willey V2

1Novo Nordisk Inc., Plainsboro, NJ, USA, 2HealthCore, Inc., Wilmington, DE, USA

Tuesday, May 17

Poster Session 3

12:15 – 1:15 PM EDT

ECONOMIC EVALUATION / DIABETES / ENDOCRINE / METABOLIC DISORDERS

EE242 | Economic Burden Among Chronic Kidney Disease (CKD) Patients with and without Type 2 Diabetes (T2D) in a Commercially Insured/Medicare Advantage (MA) Population in the United States (US)

Chung H1, Thomas N1, Willey V1, Kong SX2, Singh R2, Farej R2, Williamson T2

1HealthCore, Inc., Wilmington, DE, USA, 2Bayer U.S. LLC, Whippany, NJ, USA

Tuesday, May 17

Poster Session 4

5:30 – 6:30 PM EDT

REAL WORLD DATA & INFORMATION SYSTEMS / NO ADDITIONAL DISEASE & CONDITIONS / SPECIALIZED TREATMENT AREAS

RWD106 | Characterizing Telehealth Utilization from Administrative Claims in the US Using a Standardized Definition

Avula R1, Grabner M1, Eshete B1, Stanek E2, Willey V1

1HealthCore, Inc., Wilmington, DE, USA, 2Anthem, Inc., Indianapolis, IN, USA

Wednesday, May 18

Poster Session 5

9:00 – 10:00 AM EDT

CLINICAL OUTCOMES / MEDICAL DEVICES
Top 5% Finalist for the ISPOR 2022 Research Presentation Awards

CO158 | A Comparison of the Clinical and Economic Outcomes Associated with Short-Acting Bronchodilator Modes of Delivery Among Patients with Chronic Obstructive Pulmonary Disease (COPD)

Pham T1, Chen X1, Talavera M1, Napier M1, Willey V2

1Anthem, Inc., Indianapolis, IN, USA, 2HealthCore, Inc., Wilmington, DE, USA


*Registration is required to visit our booth (in person or virtually).